right-icon

Back to blog

Research Highlights Dissecting microglia to identify new targets in Alzheimer's disease (INPP5D) - Echelon Biosciences

Lipid phosphatase INPP5D emerges as key regulator of inflammasome in microglia

Alzheimer’s disease (AD) has long been characterized by the presence of plaques in neuronal tissue composed primarily of amyloid...

3 minute read
By Cameron Day
January 9

Alzheimer’s disease (AD) has long been characterized by the presence of plaques in neuronal tissue composed primarily of amyloid beta. More recently, there has been an increasing effort to understand the contributions of non-neuronal subtypes to AD, specifically immune cells such as microglia. Current evidence has shown that these cells are active players in the disease process and some genomic analyses have shown that innate immune activity is involved in late-onset Alzheimer's disease (LOAD). However, the precise molecular players in neuroimmune cells have yet to be defined.

Several genome-wide association studies (GWAS) have identified mutations within the INPP5D gene that are associated with LOAD. INPP5D, aka SHIP1, is known to play a role in lipid metabolism within immune cells through its action as a phosphatase on PI(3,4,5)P3 and its activity has been associated with proper functioning of macrophages and microglia. INPP5D’s role in LOAD though, remains unclear. While the GWAS analyses point to specific mutations that are predicted to affect INPP5D activity, studies of microglial expression of INPP5D in AD mice have been conflicting.

Simple schematic of INPP5D in immune activation; INPP5D appears to act as a negative regulator of inflammasome activity - Echelon Biosciences

In the current study, Chou and colleagues provide evidence that INPP5D expression is highest in the brain within microglial cells and that its expression is elevated in AD. Using a combination of immunocytochemistry and western blotting, they show that INPP5D protein is elevated at microglial plaque sites but depleted within aqueous fractions of the cell. Furthermore, these alterations in INPP5D protein appeared to be isoform specific as INPP5D found around plaque sites did not contain the active phosphatase domain. Subsequent experiments using small molecule inhibitors and genetic reduction via CRISPR demonstrated that INPP5D acts as a regulator of the inflammasome, a large multi-protein oligomer that is part of innate immune sensing. Follow-up tests using a co-culture system of microglia and neurons showed that this impairment of INPP5D activity led to wide ranging alterations in gene expression in neurons, including some known AD risk genes. Echelon's 3-a-Aminocholestane (3AC, SHIP1 Inhibitor, Cat. #B-0341) was used in this work.

The current data provide a potential link between the emerging involvement of immune cells and inflammatory pathways in AD with more canonical markers of the disease. While it remains to be seen if pathways can be exploited to treat disease, the authors propose two plausible routes that could have therapeutic significance: inhibition of inflammasome activity or targeting INPP5D. The apparent isoform specific nature of INPP5D’s involvement suggests that there may be multiple avenues to effectively target this gene and its protein.

Read the full article here:

INPP5D regulates inflammasome activation in human microglia

Nature Communications (2023)

0.2

/ 0.3

Related Articles

Stay informed with our informative blog posts.

Research Highlights
SYD-1 recruitment of neurexin for synatpogenesis - Echelon Biosciences

Lipid mediated intracellular organization of synaptic assembly

Proper nervous system function relies on small junctions between neurons that allow for communication. These are called synapses.

2 minute read
By Cameron Day
February 18

Research Highlights
Addition of anti-inflammatory lipids may alleviate immune activation from pDNA-LNPs - Echelon Biosciences

Addition of anti-inflammatory lipids blocks toxicity from pDNA-LNPs

Interest in ionizable lipids and lipid nanoparticles (LNPs) continues to accelerate, and as the field grows novel cargos and lipid

3 minute read
By Cameron Day
January 17

Research Highlights
Subpopulations of macrophages can promote tumor progression due to HA degradation and remodeling of the ECM - Echelon Biosciences

Certain macrophages degrade HA and drive tumor progression

The relationship between cancer and the immune system is complex. There is intense interest in harnessing immune cells to attack t

2 minute read
By Cameron Day
December 26

Research Highlights
Deep learning networks identify novel ionizable lipids - Echelon Biosciences

Deep learning network identifies novel, functional ionizable lipids

There has been increasing interest over the last decade in harnessing RNA for novel therapuetic modalities. With the approval of t

3 minute read
By Cameron Day
November 22

Research Highlights
hPAC channels are regulated by PI(4,5)P2 to enhance cell survival

PI(4,5)P2 regulates chloride channels during acidosis

Acidic pH is required in some intracellular organelles, but in the extracellular environment it can be highly damaging to cells. E

2 minute read
By Cameron Day
November 1

Research Highlights
Echelon Bioscience - lipid-dependent activation of STING

Lipid-dependent activation of the STING pathway

The cGAS/STING pathway is a critical part of the innate immune system that detects cytosolic DNA and promotes inflammatory respons

2 minute read
By Cameron Day
March 22

0.3

/ 0.3

Get in Touch

If you have any questions or would like to learn more about our services, feel free to reach out to us. We’re here to help!

Contact Echelon
Biosciences
Basket

Your Echelon Basket is empty.